http://www.asx.com.au/asx/statistics/announcementSearch.do?method=searchByCode&issuerCode=eft&timeFrameSearchType=D&releasedDuringCode=W
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%